Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 311

1.

Transplant infectious disease as a subspecialty: does outlining how we train define who we are?

Marty FM, Hirsch HH, Rubin RH.

Transpl Infect Dis. 2010 Jun;12(3):187-9. doi: 10.1111/j.1399-3062.2010.00518.x. No abstract available.

PMID:
20624258
2.

Diagnostic efficacy and safety of computed tomography-guided transthoracic needle biopsy in patients with hematologic malignancies.

Kallenberg MH, Gill RR, Factor RE, Bryar JM, Rubin RH, Jacobson FL, Marty FM.

Acad Radiol. 2009 Nov;16(11):1408-15. doi: 10.1016/j.acra.2009.06.008. Epub 2009 Aug 15.

PMID:
19683945
3.

Transplant infectious disease: a moving target.

Rubin RH, Hirsch HH.

Transpl Infect Dis. 2008 Feb;10(1):1-2. doi: 10.1111/j.1399-3062.2008.00297.x. No abstract available.

PMID:
18251945
4.

The value of randomized clinical trials for daily clinical practice.

de Pauw BE, Rubin RH.

Transpl Infect Dis. 2007 Sep;9(3):173-4. No abstract available.

PMID:
17692066
6.

Individualization in the management of fungal disease in the transplant recipient.

de Pauw BE, Rubin RH.

Transpl Infect Dis. 2007 Jun;9(2):87-8. No abstract available.

PMID:
17461991
7.

Principles of antimicrobial therapy in the transplant recipient.

de Pauw B, Rubin RH.

Transpl Infect Dis. 2007 Mar;9(1):1-2. Review. No abstract available.

PMID:
17313463
8.

Imaging findings in acute invasive pulmonary aspergillosis: clinical significance of the halo sign.

Greene RE, Schlamm HT, Oestmann JW, Stark P, Durand C, Lortholary O, Wingard JR, Herbrecht R, Ribaud P, Patterson TF, Troke PF, Denning DW, Bennett JE, de Pauw BE, Rubin RH.

Clin Infect Dis. 2007 Feb 1;44(3):373-9. Epub 2006 Dec 29.

PMID:
17205443
9.
10.

Poorer outcomes for recipients of heart allografts from HCV-positive donors: opening the silos.

Qamar AA, Rubin RH.

JAMA. 2006 Oct 18;296(15):1900-1. No abstract available.

PMID:
17047220
11.

The persistent challenges of bacterial infections in the transplant recipient.

Marty FM, Rubin RH.

Transpl Infect Dis. 2006 Sep;8(3):125-7. No abstract available.

PMID:
16913970
12.

Opportunities and challenges for clinical and cardiovascular research in Latin America.

Silva H, Sungar E, Kleinstiver SJ, Rubin RH.

Am J Ther. 2006 Jul-Aug;13(4):309-14.

PMID:
16858165
13.

Empiric versus preemptive therapy in the management of febrile neutropenia in the patient being treated for hematologic malignancy.

de Pauw BE, Rubin RH.

Transpl Infect Dis. 2006 Mar;8(1):1-2. No abstract available.

PMID:
16623814
14.
15.
16.

Strategy of following voriconazole versus amphotericin B therapy with other licensed antifungal therapy for primary treatment of invasive aspergillosis: impact of other therapies on outcome.

Patterson TF, Boucher HW, Herbrecht R, Denning DW, Lortholary O, Ribaud P, Rubin RH, Wingard JR, DePauw B, Schlamm HT, Troke P, Bennett JE; European Organization for Research and Treatment of Cancer (EORTC) Invasive Fungal Infections Group (IFIG); Pfizer Global Aspergillus Study Group.

Clin Infect Dis. 2005 Nov 15;41(10):1448-52. Epub 2005 Oct 13.

PMID:
16231256
17.

Darwinian competition and the pathogenesis of opportunistic infection in the transplant recipient.

Baden LR, Rubin RH.

Transpl Int. 2005 Nov;18(11):1223-5. No abstract available.

18.

Management of tuberculosis in the transplant recipient.

Rubin RH.

Am J Transplant. 2005 Nov;5(11):2599-600. No abstract available.

19.

Transplant infectious disease: a work in progress.

Rubin RH.

Transpl Infect Dis. 2005 Jun;7(2):49-50. No abstract available.

PMID:
16150089
20.

The hepatotoxicity of antifungal medications in bone marrow transplant recipients.

Fischer MA, Winkelmayer WC, Rubin RH, Avorn J.

Clin Infect Dis. 2005 Aug 1;41(3):301-7. Epub 2005 Jun 24.

PMID:
16007524
21.

Art and science in the clinical management of the patient with infection and/or cancer.

Jacobson FL, Rubin RH.

Transpl Infect Dis. 2004 Dec;6(4):139-40. No abstract available.

PMID:
15762929
22.

Principles of antimicrobial therapy in the transplant patient.

Rubin RH, Marty FM.

Transpl Infect Dis. 2004 Sep;6(3):97-100. No abstract available.

PMID:
15569224
23.

Prevention and treatment of cytomegalovirus infection in solid organ transplant recipients.

Pereyra F, Rubin RH.

Curr Opin Infect Dis. 2004 Aug;17(4):357-61. Review.

PMID:
15241082
24.
25.

Preparation and pharmacokinetics of 11C labeled stavudine (d4T).

Livni E, Berker M, Hillier S, Waller SC, Ogan MD, Discordia RP, Rienhart JK, Rubin RH, Fischman AJ.

Nucl Med Biol. 2004 Jul;31(5):613-21.

PMID:
15219280
26.
27.

Diagnosis of opportunistic infections in the transplant patient.

Rubin RH.

Transpl Infect Dis. 2003 Dec;5(4):157. No abstract available.

PMID:
14987198
28.

The sentinel chicken revisited: the impact of West Nile virus infection on transplant patients.

Baden LR, Rubin RH.

Transplantation. 2004 Feb 15;77(3):356-7. No abstract available.

PMID:
14983876
29.

Salvage therapy with voriconazole for invasive fungal infections in patients failing or intolerant to standard antifungal therapy.

Baden LR, Katz JT, Fishman JA, Koziol C, DelVecchio A, Doran M, Rubin RH.

Transplantation. 2003 Dec 15;76(11):1632-7.

PMID:
14702539
30.

Infections and anti-tumor necrosis factor alpha therapy.

Ellerin T, Rubin RH, Weinblatt ME.

Arthritis Rheum. 2003 Nov;48(11):3013-22. Review. No abstract available.

31.

Temporal aspects of transplant infectious disease.

Rubin RH.

Transpl Infect Dis. 2003 Jun;5(2):63-4. No abstract available.

PMID:
12974785
32.
33.

Granulomatous infections in the transplant patient.

Rubin RH.

Transpl Infect Dis. 2003 Mar;5(1):1-2. No abstract available.

PMID:
12791067
34.

Hispanic ethnicity, physician-patient communication, and antidepressant adherence.

Sleath B, Rubin RH, Huston SA.

Compr Psychiatry. 2003 May-Jun;44(3):198-204.

PMID:
12764707
35.

A randomized and blinded multicenter trial of high-dose fluconazole plus placebo versus fluconazole plus amphotericin B as therapy for candidemia and its consequences in nonneutropenic subjects.

Rex JH, Pappas PG, Karchmer AW, Sobel J, Edwards JE, Hadley S, Brass C, Vazquez JA, Chapman SW, Horowitz HW, Zervos M, McKinsey D, Lee J, Babinchak T, Bradsher RW, Cleary JD, Cohen DM, Danziger L, Goldman M, Goodman J, Hilton E, Hyslop NE, Kett DH, Lutz J, Rubin RH, Scheld WM, Schuster M, Simmons B, Stein DK, Washburn RG, Mautner L, Chu TC, Panzer H, Rosenstein RB, Booth J; National Institute of Allergy and Infectious Diseases Mycoses Study Group.

Clin Infect Dis. 2003 May 15;36(10):1221-8. Epub 2003 May 8.

PMID:
12746765
36.

Smallpox vaccination and the patient with an organ transplant.

Dropulic LK, Rubin RH, Bartlett JG.

Clin Infect Dis. 2003 Mar 15;36(6):786-8. Epub 2003 Mar 3.

PMID:
12627364
38.

Successful toxoplasmosis prophylaxis after orthotopic cardiac transplantation with trimethoprim-sulfamethoxazole.

Baden LR, Katz JT, Franck L, Tsang S, Hall M, Rubin RH, Jarcho J.

Transplantation. 2003 Feb 15;75(3):339-43.

PMID:
12589155
39.

Influenza and the transplant recipient.

Rubin RH.

Transpl Infect Dis. 2002 Dec;4(4):175-6. No abstract available.

PMID:
12535258
40.

The direct and indirect effects of infection in liver transplantation: pathogenesis, impact, and clinical management.

Rubin RH.

Curr Clin Top Infect Dis. 2002;22:125-54. Review. No abstract available.

PMID:
12520651
41.

Overview: pathogenesis of fungal infections in the organ transplant recipient.

Rubin RH.

Transpl Infect Dis. 2002;4 Suppl 3:12-7. Review. No abstract available.

PMID:
12486787
42.
43.
44.

The role of new diagnostic tests in transplant infectious disease.

Rubin RH.

Transpl Infect Dis. 2002 Jun;4(2):57-8. No abstract available.

PMID:
12220239
45.

Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis.

Herbrecht R, Denning DW, Patterson TF, Bennett JE, Greene RE, Oestmann JW, Kern WV, Marr KA, Ribaud P, Lortholary O, Sylvester R, Rubin RH, Wingard JR, Stark P, Durand C, Caillot D, Thiel E, Chandrasekar PH, Hodges MR, Schlamm HT, Troke PF, de Pauw B; Invasive Fungal Infections Group of the European Organisation for Research and Treatment of Cancer and the Global Aspergillus Study Group.

N Engl J Med. 2002 Aug 8;347(6):408-15.

46.

The therapeutic prescription for the transplant patient.

Rubin RH.

Transpl Infect Dis. 2002 Mar;4(1):1-2. No abstract available.

PMID:
12123419
47.

Fever, neutropenia, and the second law of thermodynamics.

Baden LR, Rubin RH.

Ann Intern Med. 2002 Jul 16;137(2):123-4. No abstract available.

PMID:
12118968
48.

Pharmacokinetic imaging: a noninvasive method for determining drug distribution and action.

Fischman AJ, Alpert NM, Rubin RH.

Clin Pharmacokinet. 2002;41(8):581-602. Review.

PMID:
12102642
49.

Mapping of local renal blood flow with PET and H(2)(15)O.

Alpert NM, Rabito CA, Correia DJ, Babich JW, Littman BH, Tompkins RG, Rubin NT, Rubin RH, Fischman AJ.

J Nucl Med. 2002 Apr;43(4):470-5.

50.

Cytomegalovirus in solid organ transplantation.

Rubin RH.

Transpl Infect Dis. 2001;3 Suppl 2:1-5. Review.

PMID:
11926743

Supplemental Content

Loading ...
Support Center